Nippon Steel shares rise after Trump approves US$14.9B steel bid
TOKYO — Nippon Steel shares rose on Monday after U.S. President Donald Trump approved its US$14.9 billion bid for U.S. Steel X.N, clearing a key hurdle in its 18-month pursuit and securing access to a vital market for its growth strategy.
The approval capped a tumultuous process marked by union resistance and two national security reviews.
Shares of Nippon, the world's fourth-largest steelmaker, gained three per cent to 2,915 yen by the mid-day break after being untraded with a glut of buy orders earlier in the day. They outperformed Tokyo's benchmark Nikkei 225 index which was up about one per cent.
On Friday, Trump signed an executive order allowing the tie-up to proceed, contingent on an agreement with the Treasury Department addressing national security concerns. The companies then announced they had signed the agreement, effectively clearing the deal.
The agreement includes $11 billion in new investments by 2028, along with commitments on governance, production and trade. Nippon Steel also confirmed plans to acquire 100 per cent of U.S. Steel's ordinary shares.
'Investors have welcomed the resolution of uncertainty surrounding the deal,' said Shinichiro Ozaki, senior analyst at Daiwa Securities.
'Overall, the agreement appears relatively reasonable in both investment size and timeframe,' he said, noting the acquisition is central to Nippon Steel's medium- to long-term growth strategy.
The deal would boost Nippon Steel's annual production capacity to 86 million metric tons from 63 million tons.
'Shares rose on long-term growth expectations, driven by preferential access to the U.S. market, where steel demand is expected to increase,' said Masayuki Kubota, chief strategist at Rakuten Securities.
Still, some investors remain concerned about near-term financial strain from the sizable investments. Also, the U.S. government's ownership in the combined company, known as the 'golden share,' has raised questions of the degree of control it can exert.
'While the risk of a capital increase hasn't completely receded, it may be less severe than expected,' Ozaki said, referring to Trump's earlier comment that the steelmaker plans to invest $14 billion in the next 14 months.
Ozaki downplayed management risk linked to the golden share, saying 'Nippon Steel anticipates growth in the U.S. market for high-end products, making production cuts and job reductions unlikely.'
(Reporting by Yuka Obayashi and Noriyuki Hirata; Editing by Christian Schmollinger)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
34 minutes ago
- Globe and Mail
EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy
GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine, Arexvy, for use in adults aged 18 years and above. With the EMA accepting the application for review, a final decision from the regulatory body in Europe is expected in the first half of 2026. Arexvy is currently approved for the prevention of lower respiratory tract disease ('LRTD') caused by RSV in all individuals aged 60 years and above, as well as for high-risk individuals aged 50-59 years. GSK is currently seeking approval for the expanded use of Arexvy in adults aged 18 years and above in the United States and Japan. Year to date, shares of GSK have risen 20.8% against the industry 's decline of 0.6%. GSK's Arexvy Sales Remain Lukewarm Arexvy was the first RSV vaccine for older adults to be approved anywhere in the world. However, sales of the vaccine have been lukewarm, mainly due to the revised recommendations for RSV vaccinations issued by the Advisory Committee on Immunization Practices ('ACIP') in June 2024. In June, the ACIP recommended the use of Arexvy for all adults aged 75 years and above. However, for adults aged 60-74 years, the ACIP recommended the vaccine only for those who are at increased risk of severe RSV disease. Arexvy generated sales worth £78 million in the first quarter of 2025, down 57% year over year due to lower demand in the United States. Other RSV Vaccine Makers in the Market Pfizer 's PFE Abrysvo is approved for the prevention of RSV-associated LRTD in all individuals aged 60 years and above, as well as in infants, through maternal immunization. PFE's Abrysvo is also approved for use in high-risk adults aged 18-59 years in the United States and Europe. Earlier this year, the ACIP recommended the expanded use of Arexvy and Abrysvo for use in adults aged 50-59 years who are at high risk for severe RSV disease. The updated ACIP recommendation lowers the recommended age for RSV vaccination from 60 years to 50 years for high-risk adults. The ACIP's recommendation is pending final approval by the director of the U.S. Centers for Disease Control and Prevention ('CDC') and the Department of Health and Human Services. Moderna 's MRNA RSV vaccine, mResvia, was approved last year by the FDA and the European Commission to prevent RSV-LRTD in older adults aged 60 years and above. Last week, the FDA approved MRNA's mResvia for use in high-risk adults aged 18-59 years. Moderna is also working on expanding the vaccine's use in pediatric populations. We note that RSV vaccine sales have been weak across the industry for the 2024-2025 vaccination season due to the restrictive recommendation issued by the U.S. CDC last year for individuals in the 60-74 age bracket. mResvia generated sales worth $2 million during the first quarter of 2025, while sales of Pfizer's RSV vaccine, Abrysvo, fell 9% year over year to $131 million. GSK's Zacks Rank GSK currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GSK PLC Sponsored ADR (GSK): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report Moderna, Inc. (MRNA): Free Stock Analysis Report
Winnipeg Free Press
40 minutes ago
- Winnipeg Free Press
Trade with China booming amid U.S. tariff war: Port of Montreal
MONTREAL – The Port of Montreal says trade with China is surging amid the U.S. tariff war and despite tensions with Beijing. In a release, the country's second-biggest port says shipments to China rose 22 per cent year-over-year in the first half of 2025. The boost has made China the port's second-largest export partner versus fifth-largest in 2024. The Port of Montreal says the boost, part of a four per cent increase in total container traffic, stems largely from U.S. President Donald Trump's trade war that has hit both Canada and China. The increase also comes despite tensions that saw Beijing roll out tariffs on Canadian agricultural products such as canola and pork in March in retaliation for the 100 per cent surtax Canada imposed on Chinese electric vehicle imports last year. Monday Mornings The latest local business news and a lookahead to the coming week. Statistics Canada says Canadian exports to the United States sagged nearly 16 per cent month-over-month in April amid the tariffs, even though the vast majority of southbound Canadian shipments are exempt. This report by The Canadian Press was first published June 16, 2025.
National Post
an hour ago
- National Post
Here's what Trump gifted Carney the last time the leaders met in Washington
OTTAWA — It may not be his favourite team but Prime Minister Mark Carney is now the proud owner of a Washington Capitals jersey emblazoned with his name and the number 24 thanks to U.S. President Donald Trump. Article content Trump gifted Carney, a die-hard Edmonton Oilers fan, the framed and mounted jersey after the leaders sat down for their first in-person meeting in the Oval Office last month, according to a public registry of disclosures. Article content That meeting laid the groundwork for what Canadian political and business leaders hope leads to a reprieve from Trump's global tariffs on autos, steel and aluminum. It is a deal the two leaders have yet to lock in as they meet again, this time in Alberta, as Canada plays host to the G7 leaders' summit. Article content Article content Gift-giving between leaders is a diplomatic custom during official visits. Another round is unfolding this week as Carney welcomes leaders from across Europe and other parts of the world for the G7 gathering. Article content For his part, the last time Carney and the rest of the Canadian delegation saw Trump, they left behind a photograph of a famous football game played between Canadian and American soldiers several months before D-Day in 1944, snapped by a Canadian military photographer. It was an image meant to signal the coming together over sports, and amid global uncertainty, the latter of which Carney is trying to bridge with a volatile Trump administration. Article content Canada also gifted Trump a hat and golf gear from the Kananaskis Country Golf Course, given that Kananaskis is where he and other G7 leaders are meeting. Article content Article content It appears Trump stuck with the sports theme for his last gift to Carney, too. Article content The Washington Capitals are not only Trump's hometown team, but also where Russian-born NHL star Alexander Ovechkin plays. Trump mentioned Ovechkin by name during his Oval Office meeting with Trump last month, which began with a wide-ranging question-and-answer session with the U.S. president, while Carney and other Canadian ministers watched on. Article content And while the president may not have gotten the team quite right for Carney, who cheers for the Edmonton Oilers, he nailed his number, given that Carney serves as Canada's 24th prime minister. Article content Most Canadians will likely be pleased that the president chose that digit over the number 51, given how often Trump has repeated his desire for Canada to become the U.S.'s '51st state.' Article content
